Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tnf Blocker
Marketing
BMS' Zeposia, AbbVie drugs shake up early IBD market
The U.S. inflammatory bowel disease market is seeing a shift in what drugs patients are offered for their first prescriptions.
Ben Adams
Dec 6, 2022 9:25am
EMA probes all JAKs after Xeljanz's safety concerns intensify
Feb 11, 2022 3:51pm
AbbVie's Humira could have a graceful biosim fall: analyst
Jul 12, 2021 11:27am
Long-term study shows safety, staying power of J&J's Stelara
Jul 9, 2021 11:10am
J&J touts Tremfya win in Humira-resistant psoriatic arthritis
Jun 3, 2021 11:40am
Bristol's Zeposia boost remission rates in ulcerative colitis
Oct 10, 2020 6:01pm
